These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30665411)

  • 21. Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping.
    Meissner PE; Coulibaly B; Mandi G; Mansmann U; Witte S; Schiek W; Müller O; Schirmer RH; Mockenhaupt FP; Bienzle U
    Br J Haematol; 2005 Nov; 131(3):395-9. PubMed ID: 16225660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Polymorphisms of Glucose-6-Phosphate Dehydrogenase in Lagos, Nigeria.
    Babalola MO; Imaga NA; Samuel TA; Diriwari IP; Kolade O; Ezeamalu I; Laoye AO; Ojewunmi OO
    Hemoglobin; 2018 Jan; 42(1):47-50. PubMed ID: 29493303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of glucose-6-phosphate dehydrogenase deficiency and haemoglobin S in high and moderate malaria transmission areas of Muheza, north-eastern Tanzania.
    Segeja MD; Mmbando BP; Kamugisha ML; Akida JA; Savaeli ZX; Minja DT; Msangeni HA; Lemnge MM
    Tanzan J Health Res; 2008 Jan; 10(1):9-13. PubMed ID: 18680959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
    Howes RE; Chan ER; Rakotomanga TA; Schulte S; Gibson J; Zikursh M; Franchard T; Ramiranirina B; Ratsimbasoa A; Zimmerman PA
    Malar J; 2017 Apr; 16(1):139. PubMed ID: 28376871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana.
    Amoah LE; Opong A; Ayanful-Torgby R; Abankwa J; Acquah FK
    Malar J; 2016 Jul; 15(1):388. PubMed ID: 27456336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study.
    Assefa A; Ali A; Deressa W; Tsegaye W; Abebe G; Sime H; Kebede A; Jima D; Kassa M; Abreha T; Teka H; Solomon H; Malone J; Shi YP; Zhou Z; Reithinger R; Hwang J
    Malar J; 2018 Oct; 17(1):388. PubMed ID: 30367627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotype analyses of haemoglobin C and haemoglobin S and the dynamics of the evolutionary response to malaria in Kassena-Nankana District of Ghana.
    Ghansah A; Rockett KA; Clark TG; Wilson MD; Koram KA; Oduro AR; Amenga-Etego L; Anyorigiya T; Hodgson A; Milligan P; Rogers WO; Kwiatkowski DP
    PLoS One; 2012; 7(4):e34565. PubMed ID: 22506028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.
    Maiga B; Dolo A; Campino S; Sepulveda N; Corran P; Rockett KA; Troye-Blomberg M; Doumbo OK; Clark TG
    Malar J; 2014 Jul; 13():270. PubMed ID: 25015414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
    Millimono TS; Loua KM; Rath SL; Relvas L; Bento C; Diakite M; Jarvis M; Daries N; Ribeiro LM; Manco L; Kaeda JS
    Hemoglobin; 2012; 36(1):25-37. PubMed ID: 21929367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
    Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
    PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Thiam F; Diop G; Coulonges C; Derbois C; Mbengue B; Thiam A; Nguer CM; Zagury JF; Deleuze JF; Dieye A
    PeerJ; 2022; 10():e13487. PubMed ID: 35811813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan.
    Moiz B; Arshad HM; Raheem A; Hayat H; Karim Ghanchi N; Beg MA
    Malar J; 2017 Oct; 16(1):426. PubMed ID: 29065882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia.
    Deng Z; Yang F; Bai Y; He L; Li Q; Wu Y; Luo L; Li H; Ma L; Yang Z; He Y; Cui L
    PLoS One; 2017; 12(5):e0177917. PubMed ID: 28531196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.
    Johnson MK; Clark TD; Njama-Meya D; Rosenthal PJ; Parikh S
    PLoS One; 2009 Sep; 4(9):e7246. PubMed ID: 19789650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic analysis and molecular basis of G6PD deficiency among malaria patients in Thailand: implications for safe use of 8-aminoquinolines.
    Boonyuen U; Jacob BAC; Wongwigkan J; Chamchoy K; Singha-Art N; Pengsuk N; Songdej D; Adams ER; Edwards T; Chamnanchanunt S; Amran SI; Latif NA; Louis NE; Chandran S
    Malar J; 2024 Feb; 23(1):38. PubMed ID: 38308253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.
    Okebe J; Amambua-Ngwa A; Parr J; Nishimura S; Daswani M; Takem EN; Affara M; Ceesay SJ; Nwakanma D; D'Alessandro U
    Malar J; 2014 Apr; 13():148. PubMed ID: 24742291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
    Bastiaens GJH; Tiono AB; Okebe J; Pett HE; Coulibaly SA; Gonçalves BP; Affara M; Ouédraogo A; Bougouma EC; Sanou GS; Nébié I; Bradley J; Lanke KHW; Niemi M; Sirima SB; d'Alessandro U; Bousema T; Drakeley C
    PLoS One; 2018; 13(1):e0190272. PubMed ID: 29324864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.
    Kone AK; Sagara I; Thera MA; Dicko A; Guindo A; Diakite S; Kurantsin-Mills J; Djimde A; Walcourt A; Doumbo O
    Malar J; 2010 Nov; 9():332. PubMed ID: 21092137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.